The Interplay between Intracellular Iron Homeostasis and Neuroinflammation in Neurodegenerative Diseases

Iron is essential for life. Many enzymes require iron for appropriate function. However, dysregulation of intracellular iron homeostasis produces excessive reactive oxygen species (ROS) via the Fenton reaction and causes devastating effects on cells, leading to ferroptosis, an iron-dependent cell death. In order to protect against harmful effects, the intracellular system regulates cellular iron levels through iron regulatory mechanisms, including hepcidin–ferroportin, divalent metal transporter 1 (DMT1)–transferrin, and ferritin–nuclear receptor coactivator 4 (NCOA4). During iron deficiency, DMT1–transferrin and ferritin–NCOA4 systems increase intracellular iron levels via endosomes and ferritinophagy, respectively. In contrast, repleting extracellular iron promotes cellular iron absorption through the hepcidin–ferroportin axis. These processes are regulated by the iron-regulatory protein (IRP)/iron-responsive element (IRE) system and nuclear factor erythroid 2-related factor 2 (Nrf2). Meanwhile, excessive ROS also promotes neuroinflammation by activating the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). NF-κB forms inflammasomes, inhibits silent information regulator 2-related enzyme 1 (SIRT1), and induces pro-inflammatory cytokines (IL-6, TNF-α, and IL-1β). Furthermore, 4-hydroxy-2,3-trans-nonenal (4-HNE), the end-product of ferroptosis, promotes the inflammatory response by producing amyloid-beta (Aβ) fibrils and neurofibrillary tangles in Alzheimer’s disease, and alpha-synuclein aggregation in Parkinson’s disease. This interplay shows that intracellular iron homeostasis is vital to maintain inflammatory homeostasis. Here, we review the role of iron homeostasis in inflammation based on recent findings.


Introduction
Iron is a mineral nutrient essential for the survival of living organisms. It is a cofactor of many vital enzymes and has a crucial role as a heme component in transferring molecular oxygen to cells. Iron is known as the most abundant transition metal in the brain. However, iron does not exist in the brain at birth [1]. Instead, iron levels are drastically increased during adolescence and then maintained at constant levels [2]. Excessive iron can increase the labile iron pool (LIP), raising the levels of intracellular reactive oxygen species (ROS) [3][4][5][6], and iron depletion can promote the dysfunction of iron-dependent enzymes. Disruption of iron regulation is known to be involved in the pathogenesis of various neurodegenerative disorders [7][8][9][10]. Most of the total brain iron exists in the glial cells, such as astrocytes, oligodendrocytes, and microglia, rather than in the neurons [11] and is bound to ferritin, an iron storage protein [12]. Consequently, neurons are more vulnerable than glial cells to alterations in the iron balance.
Considering that studies of ferroptosis have newly elucidated iron's role in cell death, the present review aims to describe the relationship between intracellular iron homeostasis and neuroinflammation based on recent studies and findings.
During an iron shortage, iron levels are increased by iron influx proteins, such as DMT1, Tf, TfR, and hepcidin. By contrast, iron-efflux-related proteins, such as FPN1, increase under iron-replete conditions. The IRP/IRE system finely regulates these opposed processes. Once iron enters the intracellular space, iron is trafficked by carrier proteins, such as PCBPs, to FTH1/FTL for storage and enzymes for activation. When cellular iron is lacking, FTH1/FTL vesicles release iron to the cytoplasm via NCOA4-mediated ferritinophagy to increase cellular iron contents ( Figure 2). The IRP/IRE system. IRPs consist of two proteins, IRP1 and IRP2. Under iron-rich conditions, iron forms iron-sulfur clusters. Iron-sulfur clusters bind to IRP1. IRP1 acts as c-aconitase. Additionally, iron-sulfur clusters bind to FBXL5 (not described) and mediate IRP2 ubiquitinationdependent degradation. Eventually, inhibition of IRPs leads to the degradation of iron uptake-related mRNAs by the endonuclease. By contrast, under iron shortage conditions, IRPs bind to the IRE within mRNA. This stabilizes the mRNAs or prevents their translation in the nucleus. DMT1, divalent metal transporter 1; FPN1, ferroportin 1; FTH1, ferritin heavy chain; FTL, ferritin light chain; IRE, iron-responsive element; IRP, iron-regulatory protein; IRP1, iron-regulatory protein 1; IRP2, iron-regulatory protein 2; Tfr, transferrin receptor.
During an iron shortage, iron levels are increased by iron influx proteins, such as DMT1, Tf, TfR, and hepcidin. By contrast, iron-efflux-related proteins, such as FPN1, increase under iron-replete conditions. The IRP/IRE system finely regulates these opposed processes. Once iron enters the intracellular space, iron is trafficked by carrier proteins, such as PCBPs, to FTH1/FTL for storage and enzymes for activation. When cellular iron is lacking, FTH1/FTL vesicles release iron to the cytoplasm via NCOA4-mediated ferritinophagy to increase cellular iron contents ( Figure 2).
A recent study showed that PCBP1 knockdown could promote ferritiniophagy and lipid peroxidation via binding to the 3′-UTR on beclin 1 (BECN1) mRNA and arachidonate 15-lipoxygenase (ALOX15) mRNA [44]. Although the process of intracellular iron homeostasis and related molecules are known, and new functions of the molecules have been discovered, more studies are needed about the interplay between iron redox homeostasis and neuroinflammation. Thus, this section describes the interaction between iron-related molecules and inflammation. . Cellular iron regulation in ferritinophagy. Fe 3+ is reduced to Fe 2+ via Dcytb, and Fe 2+ is then transported into cells via Tf-Tfr or DMT1. Oxidized Fe 3+ is encapsulated by vesicles called endosomes. Next, Steap3 in the vesicles reduces Fe 3+ to Fe 2+ and releases it into the cytoplasm. Fe 2+ binds to PCBP1 or PCBP2 and is delivered to FTH1, the mitochondria, or FPN1. FTH1 interacts with NCOA4 to store iron. Meanwhile, the interaction between hepcidin and FPN1 blocks the leakage of intracellular iron. When iron is deficient, the FTH1-NCOA4 complex releases iron through ferritinophagy. When iron is repleted, FPN1 exports iron into the extracellular space. In the extracellular space, Fe 2+ is oxidized to Fe 3+ by HEPH. Intracellular iron responds to H 2 O 2 and produces • OH. ROS damages organelles. A white circle with numbers means iron movement by endocytosis. A yellow circle with numbers shows iron movement through a channel. DMT1, divalent metal transporter 1; DcytB, duodenal cytochrome B; Fe 2+ , ferrous iron; Fe 3+ , ferric iron; FTH1, ferritin heavy chain; FTL, ferritin light chain; FPN1, ferroportin 1; GSH, glutathione; HEPH, hephaestin; HERC2, HECT domain and RCC1-like domain 2; • OH, hydroxyl radical; H 2 O 2 , hydrogen peroxide; LC3, microtubule-associated protein 1A/1B-light chain 3; LIP, labile iron pool; NCOA4, nuclear receptor coactivator 4; PCBP1, poly(rC)-binding protein 1; PCBP2, poly(rC)-binding protein 2; ROS, reactive oxygen species; Steap3, six-transmembrane epithelial antigen of prostate family member 3; Tf, transferrin; TfR, transferrin receptor.
A recent study showed that PCBP1 knockdown could promote ferritiniophagy and lipid peroxidation via binding to the 3 -UTR on beclin 1 (BECN1) mRNA and arachidonate 15-lipoxygenase (ALOX15) mRNA [44]. Although the process of intracellular iron homeostasis and related molecules are known, and new functions of the molecules have been discovered, more studies are needed about the interplay between iron redox homeostasis and neuroinflammation. Thus, this section describes the interaction between iron-related molecules and inflammation.

Hepcidin
Hepcidin is a peptide hormone produced by the liver in response to increased iron levels and inflammation. Hepcidin is involved in iron homeostasis, absorbing dietary iron, releasing recycled hemoglobin iron from macrophages, and transferring stored iron from hepatic cells [45,46]. Inflammation induces hepcidin release and reduces blood iron (i.e., hypoferremia). This increases host resistance to microbial infection and results in anemia. Hepcidin controls cellular iron efflux by interacting with FPN1. The hepcidin-FPN1 response promotes iron uptake [47] (Figure 2). The transcription of hepcidin is mainly regulated by the bone morphogenetic protein (BMP)/suppressor of mothers against the decapentaplegic (SMAD) pathway [48]. A high iron level stimulates BMP6 expression and leads to hepcidin expression by binding to a BMP-responsive element on the hepcidin gene promoter. An increase in hepcidin hinders iron efflux from the cell. Hepcidin levels are closely linked to IL-6 levels. IL-6 increases hepcidin and accumulates iron in the intracellular space while promoting the degradation of FPN1 by hepcidin [49,50]. Accumulated iron in the cell increases the Fenton reaction and ultimately produces excessive ROS, causing inflammation and cellular damage [51,52].

NCOA4
NCOA4 is a selective cargo receptor in ferritinophagy. NCOA4 finely regulates cellular iron homeostasis by anticipating the autophagic degradation of ferritin. Under ironreplete cellular conditions, HERC2-mediated ubiquitylation facilitates the turnover of NCOA4. However, under iron-deficient cellular conditions, NCOA4 is stabilized, thereby promoting ferritinophagy, a type of autophagy, by forming an autophagosome and directing it to the lysosome, which, in turn, increases cellular iron levels [20]. Thus, two selective processes occur according to whether NCOA4 binds to iron. In cells with excess iron, the direct binding of cytosolic iron to NCOA4 mediates its interaction with HERC2 and subsequent degradation, and ferritin is not degraded, thus retaining its stored iron. NCOA4mediated iron homeostasis also facilitates ferroptosis by increasing cellular iron levels via ferritinophagy [19,53] (Figure 2).

PCBPs
PCBPs are multifunctional proteins that regulate gene expression and bind to iron to form delivery complexes [54]. These complexes deliver iron to other molecules requiring iron for activation. PCBP1 and PCBP2 are essential to maintain the LIP in cells. PCBP2 interacts with DMT1 and FPN1 and directly regulates Fe 2+ trafficking in and out of the cytosol [55] (Figure 2), whereas PCBP1 plays various roles in the regulation of gene expression as a major iron chaperon [22,44,55,56]. A recent study showed that PCBP1 could regulate ferritinophagy via the interaction between BECN1, an autophagy regulator protein, and PCBP1. PCBP inhibited BECN1 translation by binding to the CU-rich elements in the 3 -UTR of BECN1 mRNA. This binding hampered microtubule-associated protein 1A/1Blight chain 3 (LC3) from forming autophagosomes [44]. In addition, inhibiting PCBPs leads to an iron shortage response because PCBPs cannot deliver iron to iron-related proteins using iron as a cofactor. Although the extracellular iron continuously enters cells, BECN1 promotes the formation of autophagosomes to release stored iron due to the absence of iron delivery proteins interacting with LC3 and NCOA4. In the last stage, autophagosomes fuse lysosomes, called autolysosomes, and release iron into the cytoplasm [19]. Increased iron can expedite the Fenton reaction, and increased ROS damages mitochondria. This aggravates an iron famine because mitochondria can induce the iron starvation response [57][58][59]. Moreover, constitutive deletion of PCBP1 and PCBP2 genes results in early embryonic lethality in mice [60]. Especially, PCBP1 can form a PCBP1-GSH-Fe 2+ complex and balance the level of cytosolic LIP while delivering Fe 2+ to an enzyme or ferritin. This process decreases the production of cellular ROS by the Fenton reaction [61,62] and ultimately attenuates lipid peroxidation via NRf2 activation.

IRP/IRE System
The IRP/IRE system consists of IRP1, IRP2, and IRE. IRP1 and IRP2 are the core molecules responsible for iron homeostasis. IRP1 and IRP2 bind to the specific region of target mRNAs called IREs [42]. Under iron deficiency conditions, IRP1 and IRP2 bind to IREs in the UTRs of the iron homeostasis-related mRNAs: ferritin, FPN1, and TfR. The binding of IRPs to the 5 -UTR of IREs in ferritin and FPN1 blocks translation initiation by interfering with the recruitment of the small ribosomal subunit [43]. In contrast, IRPs work differently with TfR mRNA. IRPs protect TfR mRNA from nucleolytic degradation by binding to its 3 -UTR. These reciprocal effects boost iron uptake and repress iron efflux. Under iron-replete conditions, the lack of interaction between IRPs and IREs increases the synthesis of ferritin and FPN1. However, it does not decrease TfR synthesis because TfR mRNA is degraded by endonuclease [63] (Figure 1). As a result, the iron uptake decreases, but the export of iron increases. Meanwhile, activation of the IRP/IRE system can be diminished by ROS. This results in iron deficiency in cells.

DMT1
DMT1 (SLC11A2) transports Fe 2+ out of endosomes. Ferrireductases on the cell surface reduce most non-Tf-bound iron and then enter the cytosol by DMT1. Expression of DMT1 is elaborately managed in an iron-dependent manner. DMT1 mRNA has the IRE region in the 3 -UTR, and IRPs bind to IREs under iron deficiency [64]. The binding of IRPs to IREs stabilizes DMT1 mRNA and increases DMTI1 synthesis. There is also the non-IREcontaining region on DMT1 mRNA. Alternative splicing determines DMT1 fates, such as DMT1-I with IRE or DMT1-II without the IRE. The DMT1-II isoform is unresponsive to posttranscriptional regulation by intracellular iron concentration because it does not include the IRE [65,66]. Most cells implement the Tf-TfR-mediated process to uptake iron. The Tf-TfR complex forms an endosome with DMT1 and six-transmembrane epithelial antigen of prostate family member 3 (Steap3), acidified to pH 5.5-6.0 via an ATP-dependent proton pump [67]. The Tf-Fe 3+ complex is released from Tf due to low pH, and then Steap3 reduces Fe 3+ to Fe 2+ , transferring Fe 2+ into the cytosol using DMT1 [68]. This process provides cells with Fe 2+ associated with iron delivery proteins, such as PCBP1 and PCBP2, in the cytosol ( Figure 2). DMT1 contributes to the pathogenesis of Parkinson's disease (PD). Julio et al. suggested that DMT1 expression was increased in PD model mice and patients with PD. In contrast, mutated DMT1 protected rodents from parkinsonism induced by treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 6-hydroxydopamine [69]. Given that inflammatory cytokines (e.g., TNF-α and IFN-γ) increased DMT1 expression [70], it is reasonable for DMT1 to correlate with inflammation associated with PD development. A study showed that glial cells, activated by inflammatory cytokines, promoted PD progress [71]. Pioglitazone (a peroxisome proliferator-activated receptor alpha [PPAR-α] agonist) effectively attenuated the loss of dopaminergic neurons in substantia nigra in mice by suppressing MPTP-induced microglial activation. Interestingly, caspase inhibitors could not inhibit the degenerative process when dopaminergic neurons were already engaged in apoptosis or autophagic degeneration [72]. Instead, it was efficient for dopaminergic neurons, yet arrived at the final stage [73]. This means that inhibition of DMT1-induced inflammation may impact cell stress during PD, and therapy mainly focuses on the preventive aspect by regulating inflammation.

Ferritin
Ferritin is the main iron storage protein consisting of 24 subunit shells. It has two distinct subunits with different amino acid sequences, designated as FTH1 and FTL. Ferritin synthesis is regulated at the post-translational level through the IRP/IRE system, α-syn, and amyloid precursor protein (APP) [74]. The efficiency of IRE binding to ferritin mRNA is determined by iron (IRP1) and the redox status (IRP2). When iron levels are high, IRP1 forms an iron-sulfur cluster and activates aconitase. However, IRP1 loses RNA-binding activity [75]. IRP2 does not have an iron-sulfur cluster and is regulated by the ubiquitin-proteosome system (UPS) by an E3 ubiquitin ligase complex [76] (Figure 1). Heme is also known to regulate ferritin synthesis. This occurs via BTB and CNC homology 1 (Bach1) binding and IRP2 [77]. FTH1 has a di-iron ferroxidase center that oxidizes Fe 2+ to Fe 3+ , whereas FTL is considered to form the nucleation site in the mineral iron core [16]. The ferritin complex (FTH1 and FTL) can contain a few hundred to five thousand iron atoms [78]. Fe 2+ is oxidized to Fe 3+ via the ferroxidase in FTH1, and subsequently, Fe 3+ moves toward the nucleation site in FTL and is mineralized and stored. This process is important for efficiency because iron mineralization of ferritin (specifically, FTL) can foster iron oxidation and accelerate circulation between Fe 2+ and Fe 3+ in the ferritin complex. However, FTL cannot oxidize Fe 2+ to Fe 3+ [79,80] (Figure 2). Under iron starvation conditions, the ferritin complex releases stored iron by promoting autophagy (i.e., ferritinophagy) [19,53]. Increased iron levels help to maintain cellular iron levels and activate iron-dependent enzymes, but excessive iron can increase ROS generation through the Fenton reaction and ultimately induce cell death due to failure in redox control (i.e., ferroptosis) [5,81]. During the inflammation process, ferritin synthesis is indirectly promoted by the IL-6-signal transducer and activator of transcription 3 (STAT3) pathway via hepcidin [82,83] (Figure 3).

Ferroportin
FPN1 is the sole iron export protein. When iron is overloaded, FPN1 promotes iron efflux. Fe 2+ binds to the PCBP2 protein and is then transported to FPN1. This balances cellular iron levels [47,97,98]. The degradation of FPN1 is closely related to hepcidin, as mentioned above [47,49]. A lack of FPN1 increases the amounts of intracellular iron and facilitates the Fenton reaction [99] (Figure 2). ROS generated by the Fenton reaction attack PUFAs and promote lipid peroxidation by producing lipid peroxyl radicals. Eventually, lipid peroxyl radicals lead to ferroptosis. Accordingly, the expression of FPN1 is tightly regulated in cells [100] (Figure 4).

Neuroinflammation
Neuroinflammation in the CNS depends on specific cell types: microglia, astrocytes, endothelial cells, and pericytes. Additionally, disruption of the blood-brain barrier leads to the inflammatory response via macrophages [101]. Iron accumulation is identified in many neurodegenerative diseases, including Alzheimer's disease (AD), PD, and amyotrophic lateral sclerosis (ALS). In these neurodegenerative diseases, inflammation is promoted in glial cells and neurons, but there is still a lack of understanding of the role of iron in neuroinflammation. Considering the active redox trait of iron, increased iron levels in the intracellular space can have detrimental effects because they can produce • OH through the Fenton reaction and subsequently damage biomolecules, causing cell death [102]. In ferroptosis, • OH induces lipid peroxidation and promotes inflammation by activating cyclooxygenase-2 (COX2) [103,104]. Recently, researchers have been studying the relationship between ferroptosis and neurodegenerative diseases [105,106]. However, a few studies have shown a relationship between iron and neuroinflammation.
tions, the ferritin complex releases stored iron by promoting autophagy (i.e., ferritinophagy) [19,53]. Increased iron levels help to maintain cellular iron levels and activate irondependent enzymes, but excessive iron can increase ROS generation through the Fenton reaction and ultimately induce cell death due to failure in redox control (i.e., ferroptosis) [5,81]. During the inflammation process, ferritin synthesis is indirectly promoted by the IL-6-signal transducer and activator of transcription 3 (STAT3) pathway via hepcidin [82,83] (Figure 3). Figure 3. The regulation of cellular redox balance and inflammation. In redox regulation, ROS produced by IL-6 or the Fenton reaction promotes the dissociation of Nrf2 from Keap1 and activates Nrf2. Activated Nrf2 is translocated to the nucleus and initiates the transcription of antioxidant enzymes and proteins requiring iron. This process protects cells from ROS. During inflammation, ROS, DAMPs, or LPS activate NF-κB signal transduction by eliminating IκB-α via ubiquitination. NF-κB moves to the nucleus and induces the transcription of pro-inflammatory cytokines. In this process, inflammasomes are activated, and inflammation is increased. To prevent excessive inflammation, the Nrf2 pathway is activated, which suppresses inflammation-related proteins, such as Figure 3. The regulation of cellular redox balance and inflammation. In redox regulation, ROS produced by IL-6 or the Fenton reaction promotes the dissociation of Nrf2 from Keap1 and activates Nrf2. Activated Nrf2 is translocated to the nucleus and initiates the transcription of antioxidant enzymes and proteins requiring iron. This process protects cells from ROS. During inflammation, ROS, DAMPs, or LPS activate NF-κB signal transduction by eliminating IκB-α via ubiquitination. NF-κB moves to the nucleus and induces the transcription of pro-inflammatory cytokines. In this process, inflammasomes are activated, and inflammation is increased. To prevent excessive inflammation, the Nrf2 pathway is activated, which suppresses inflammation-related proteins, such as inflammasomes, MIP2, MCP1, and the NF-κB pathway. Additionally, SIRT1 acts as a regulator and inhibits the activation of NF-κB. NF-κB also regulates the activation of the uncontrolled redox system by inhibiting Nrf2 activation. ARE, antioxidant response element; ATP, adenosine triphosphate; DAMP, damageassociated molecular pattern; FPN1, ferroportin 1; FTH1, ferritin heavy chain; • OH, hydroxyl radical; H 2 O 2 , hydrogen peroxide; IκB-α, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; IKKα, IκB kinase alpha; IL-1β, interleukin-1β; IL-6, interleukin-6; KEAP1, Kelch-like ECH-associated protein 1; LPS, lipopolysaccharide; MCP1, monocyte chemoattractant protein 1; MIP2, macrophage inflammatory protein 2; MyD88, myeloid differentiation primary response protein 88; NF-κB, nuclear factor-kappa B; Nrf2, nuclear factor erythroid 2-related factor 2; P, phosphorylation; PCBP2, poly(rC)-binding protein 2; PIR, pirin; ROS, reactive oxygen species; SIRT1, silent information regulator factor 2-related enzyme 1; STAT3, signal transducer and activator of transcription 3; TLR2, Toll-like receptor 2; TLR4, Toll-like receptor 4; TNF-α, tumor necrosis factor-alpha; Ub, ubiquitin. efflux. Fe 2+ binds to the PCBP2 protein and is then transported to FPN1. This balances cellular iron levels [47,97,98]. The degradation of FPN1 is closely related to hepcidin, as mentioned above [47,49]. A lack of FPN1 increases the amounts of intracellular iron and facilitates the Fenton reaction [99] (Figure 2). ROS generated by the Fenton reaction attack PUFAs and promote lipid peroxidation by producing lipid peroxyl radicals. Eventually, lipid peroxyl radicals lead to ferroptosis. Accordingly, the expression of FPN1 is tightly regulated in cells [100] (Figure 4).

NF-κB
NF-κB consists of five transcription factors; NF-κB1 (p105/p50), NF-κB2 (p100/p52), RelA (p65), RelB, and c-Rel. Activated NF-κB participates in the inflammatory response by promoting pro-inflammatory genes. Activation of NF-κB leads to two distinct path-ways: canonical and noncanonical. These two distinct pathways have different stimuli. In the canonical pathway, inflammatory stimuli, such as cytokines, antigens, and damageassociated molecular patterns (DAMPs), release p65/p50 dimers from IκBα, phosphorylating IκBα and degrading it through the UPS. Free p65/p50 dimers are translocated to the nucleus, activating the transcription of NF-κB target genes [107]. The trigger is a subset of tumor necrosis factor receptor (TNFR) superfamily members in the noncanonical pathway. They activate NF-κB-inducing kinase (NIK), and NIK phosphorylates IκB kinase alpha (IKKα). Following the phosphorylation cascade, p52/RelB enters the nucleus and promotes the expression of NF-κB target genes. NF-κB signaling is important for immune cell development [108] (Figure 3). Given that Toll-like receptors (TLRs, an inducer of inflammatory response) of microglia are highly expressed in AD [109], it is reasonable for NF-κB to be involved in AD progression. TLRs promote the canonical NF-κB signal transduction, which leads to chronic inflammation in AD due to stimuli, such as cytokines and Aβ plaques [110]. Patients with PD showed increased levels of OS. Immunohistochemical analyses of brain sections with PD showed increased activation of NF-κB, consistent with elevated levels of OS and decreased Nrf2 activation [111]. Interestingly, Fe 2+ is related to excessive abnormal ROS generation in neuroblastoma. Fe 2+ inhibits the Nrf2 signal pathway, exacerbates mitochondrial dysfunction, and promotes α-syn aggregation [112] (Figure 4). Recent studies revealed that severe OS could promote α-syn proteostasis [41,113], indicating that OS increased by Fe 2+ -induced inhibition of Nrf2 may promote neuroinflammation by interfering with the Nrf2 countereffect on NF-κB activation in PD. In contrast, NF-κB is also known to induce FTH1 expression. Increased FTH1 can indirectly inhibit ROS accumulation by sequestrating iron and reducing the Fenton reaction, leading to the attenuation of apoptosis [114]. This process can oppose the detrimental role. The final effect of these two opposing roles may be determined by the antioxidant level.

Inflammasome
Inflammasomes are cytosolic molecular complexes that promote inflammatory responses to activate immune defenses. Inflammasomes are classified as nucleotide-binding oligomerization-like receptor (NLR) domain and leucine-rich repeat and pyrin domaincontaining protein 1 (NLRP1), NLRP3, NLR family CARD domain-containing 4 (NLRC4), AIM2, and pyrin inflammasomes [142]. Inflammasomes consist of the NLR protein or AIM2-like receptor, apoptosis-associated speck-like protein containing a CARD (ASC), and pro-caspase-1. The NLR protein can sense an intracellular signal that promotes the formation of inflammasomes. Once inflammasomes are formed, activated caspase-1 mediates the catalytic cleavage and release of the pro-forms of pro-inflammatory cytokines, such as IL-1β and IL-18 [143]. In the CNS, inflammasome formation occurs in microglia, neurons, and astrocytes. Especially, NLRP3 inflammasome plays a crucial role in the neuroinflammation response [144]. NLRP3 inflammasome and NLRP3-dependent inflammatory cytokines are found in the periphery plasma of patients with PD [145]. Aggregated α-syn released from neurons can interact with TLRs in microglia, which activates NLRP3 inflammasome in microglia. In turn, NF-κB is translocated to the nucleus, leading to an increase in pro-inflammatory cytokines. Furthermore, pathological α-syn impairs mitochondrial homeostasis, interfering with protein transport via the translocase of the outer membrane (TOM) receptor, such as TOM20, and inhibiting SIRT3 activation in the mitochondria of microglia [146]. Meanwhile, mitochondrial ROS activates nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2) in microglia, resulting in microglial activation and neurotoxicity [147], ultimately leading to neuroinflammation and neuronal dysfunction [148][149][150]. However, another study reported that macrophages could regulate the inflammatory response via the NF-κB-p62-mitophagy pathway (a type of autophagy). NF-κB promotes p62 activation, an adaptor that binds polyubiquitinated proteins and helps to form autophagosomes [37]. Mitophagy eliminates damaged mitochondria, restrains NLRP3 activation, and, ultimately, attenuates the inflammatory response [151]. In AD, there are two main inflammasome activation pathways: the MYD88-dependent pathway (signal 1) and the ATP-dependent pathway (signal 2). The MYD88-dependent pathway utilizes DAMPs as a trigger. DAMPs stimulate NF-κB activation via TLRs in microglia ( Figure 3). This increases the production of pro-inflammatory cytokines and facilitates the formation of inflammasomes. Activated inflammasomes trim pro-inflammatory cytokines into active forms. IL-1β is intimately linked to the pathogenesis of AD. Among other pro-inflammatory cytokines, IL-1β levels are increased in patients with AD. In signal 2, P2X purinergic receptor 7 (P2X7R), a trimeric ATP-gated cation channel, is a protagonist in forming inflammasomes. A study reported that P2X7R is related to chronic inflammatory neurological disorders [152]. P2X7R was highly expressed in immune cells, such as macrophages, mast cells, microglia, and oligodendrocytes, but to a lesser extent in astrocytes and neurons. In high-ATP conditions, P2X7R was activated, promoting the activation of inflammasomes [153].

NRF2
Nrf2 is known as a master regulator of cytoprotection against oxidative and xenobiotic stresses [154]. Nrf2 is a ubiquitously expressed redox-sensitive transcription factor with an important role in redox homeostasis and cell inflammation. Nrf2 promotes the expression of antioxidant enzymes and anti-inflammatory molecules [155][156][157]. Under normal conditions, Nrf2 is maintained at low basal levels in the cytoplasm because of its degradation by the UPS. In a normal state, Kelch-like ECH-associated protein 1 (Keap1), an adaptor protein for a cullin 3 (Cul3)-based ubiquitin E3 ligase, tightly binds to Nrf2, targeting Nrf2 for degradation by the proteasome [158][159][160]. However, OS and Nrf2inducing chemicals reduce the E3 ligase activity of the Keap1-Cul3 complex and liberate Nrf2 from the Nrf2-Keap1 complex. This stabilizes Nrf2 against degradation, and Nrf2 is translocated to the nucleus. Continuously, Nrf2 binds to the antioxidant response element (ARE) that has the promoter for transcription of phase II detoxifying antioxidant enzymes. Once Nrf2 binds to the ARE motif, antioxidant enzymes are transcribed, and cellular antioxidant systems are simultaneously activated to protect cells from harmful molecules [161,162] (Figure 3). Activation of antioxidants is intertwined with inflammation. They block inflammatory mediators, including IL-6, TNF-α, monocyte chemoattractant protein 1 (MCP1), and macrophage inflammatory protein 2 (MIP2) [163]. This process is important in the progression of neurodegenerative diseases. A study showed that inflammatory markers, such as inducible nitric oxide synthase (iNOS), TNF-α, and IL-6, were increased in the hippocampus of Nrf2-knockout mice [164]. Despite its anti-inflammatory role, Nrf2 has Janus-like roles. On the one hand, Nrf2 inhibits NLRP3 inflammasome by increasing the expression of NQO1, one of the antioxidant enzymes induced by Nrf2, in macrophages [165,166]. On the other hand, Nrf2 has been shown to activate NLRP3 and AIM2 inflammasomes [167]. However, many studies demonstrated that Nrf2 negatively regulated NF-κB and vice versa. Nrf2 negatively influenced NF-κB-induced inflammation in three aspects: degradation of IKKβ by Keap1 [168], inhibition of OS by activation of Nrf2 induced by the cyclopentenone prostaglandin 15d-PGJ2 [169], and forming a complex with the competitive Nrf2 transcriptional coactivator CREB-binding protein (CBP) [170,171]. The result of three aspects ends in the inactivation of NF-κB. Furthermore, Nrf2-induced heme oxygenase 1 (HO-1) prohibited the translocation of NF-κB to the nucleus [172]. The disease phase affects the Nrf2 response. In the frontal cortex of patients with AD, NQO1 activity was increased during the initial stages of AD but reduced or maintained in the latter stage of AD [173]. This inducible cellular defense system helps cells resist unfavorable environments. In PD, Nrf2 can effectively reduce α-syn aggregation [174], whereas Nrf2 deficiency leads to increased α-syn aggregation, loss of neurons, and enhanced inflammation [175] ( Figure 4).
Nrf2 is also closely associated with iron metabolism [176][177][178]. Nrf2 coordinates iron homeostasis within LIPs. Especially, Nrf2 promotes ferritin expression. Nrf2-deficient mice showed lower basal FTH1 and FTL levels than wild-type mice [179,180]. The regulation mechanism was uncovered by Pietsch et al. They proved that Nrf2 is directly bound to the ARE on FTH1 mRNA [181], suggesting that Nrf2 activation promotes iron storage and reduces labile iron levels by boosting ferritin expression. Meanwhile, Nrf2 is also involved in FPN1 expression. Nrf2 activation may displace Bach1 and inhibit the transcription of HO-1 and FPN1 genes through direct DNA binding [182]. Other studies suggested that Nrf2 activators (e.g., diethyl malate, sulforaphane) could increase FPN1 mRNA in murine macrophages in an iron-independent manner. Interaction between Nrf2 and FPN1 helped macrophages to offset the suppression of FPN1 mRNA expression following lipopolysaccharide (LPS) treatment [183]. Furthermore, Nrf2 increases pirin (PIR) transcription. PIR is known to regulate NF-κB transcriptional signaling and has an enzymatic redox function. Activation of PIR requires iron as a cofactor to form a PIR-iron complex. The PIR-iron complex alters the allosteric capability of NF-κB to bind to DNA [184,185]. Ultimately, the PIR-iron-NF-κB complex increases the NF-κB transcription of target genes (Figure 4). Nrf2 knockdown in HeLa cells reduced PIR expression, whereas Nfr2 overexpression increased the PIR mRNA level by 30% compared to the control [186]. Overall, Nrf2 activation plays a key role in cellular iron homeostasis and helps protect cells from oxidative damage.

Conclusions and Perspectives
Iron homeostasis is critical for the functioning of cells and organisms. Impairment of iron homeostasis can have devastating effects on human health. Ferroptosis induced by an imbalanced iron level emphasizes the importance of iron homeostasis. ROS generated by the Fenton reaction stimulate cellular antioxidant systems. However, cell damage occurs when the ROS burden exceeds the capacity of the antioxidant systems. Increased IL-6 in the immune response promotes the interaction between hepcidin and FPN1. This response inhibits the utilization of iron, an essential element of antigens. However, this process accelerates detrimental effects by promoting iron uptake instead of enhancing the immune system in extracellular space. Cellular iron shortage can also facilitate iron uptake through the DMT1-Tf-TfR complex and stimulates ferritinophagy via NCOA4. Increased intracellular iron is transferred to iron-dependent enzymes and inhibits ferritin (FTH1/FTL) turnover through PCBPs. Nevertheless, excessive iron can accelerate the Fenton reaction and lead to excessive ROS generation, boosting inflammation and cellular damage. Cells initiate the transcription of antioxidants using the Nrf2-ARE pathway to hinder severe injury. In this respect, the IRP/IRE system has a crucial role in the relationship between iron homeostasis and inflammation. Activation of Nrf2 inhibits the NF-κB pathway by preventing the degradation of IκB-α. This hinders the translocation of NF-κB to the nucleus and the transcription of pro-inflammatory cytokines. Prolonged activation of NF-κB promotes chronic inflammation and OS. In AD, Aβ 1-40/42 binds to redox-active metal ions (Cu 2+ , Zn 2+ , and Fe 2+ ) to form Aβ oligomers and, ultimately, Aβ fibrils (components of amyloid plaques). In forming Aβ-metal ions complex, OS and APP increase the cellular iron influx. Interestingly, AD progression is related to ferroptosis. In ferroptosis, iron promotes ironbased lipid peroxidation and ultimately produces 4-HNE. Continuously, 4-HNE induces tau protein aggregation, producing NFTs through modifying tau conformation. Moreover, 4-HNE can conjugate with mitochondrial proteins involved in energy production. This conjugation results in a conformational change and increases electron leakage from the electron transport chain, causing ROS generation. Consequently, this decreases ATP production and increases the level of OS due to mitochondrial dysfunction. In addition, COX2 is activated during ferroptosis and promotes inflammation. In the initial stage of PD, 4-HNE promotes α-syn aggregation. Suppression of the Nrf2 pathway by Fe 2+ may promote OS and α-syn aggregation due to increased OS in PD. Iron-associated ROS production also facilitates inflammasome formation via NF-κB or P2X purinoceptor 7 (P2XR7) activation. Considering the importance of the antioxidant system, NAD(P)H-dependent enzymes may also be involved in regulating iron-induced inflammation. Enzymes requiring NAD(P)H possess antioxidant properties and a role as an energy provider. As an energy provider, a representative enzyme is NQO1. NQO1 increases NAD + and activates SIRT1. Activated SIRT1 can inhibit NF-κB via deacetylation of p65. This process may decrease OS and inflammation. In addition, PGC-1 activation by SIRT1 may compensate for the loss of mitochondria by promoting mitochondrial biogenesis. This may offer a practical benefit for patients with mitochondria dysfunction.
The relationship between iron and cell death has been known for over 30 years, but advanced research on the mechanism of iron-dependent cell death has recently been achieved in the cancer field. New findings will help to understand iron and diseases. Thus, the interplay between iron, cell death, and inflammation in neurobiology needs to be re-examined considering recent findings. The imbalance of iron homeostasis and excessive inflammation can cause detrimental effects on cells, highlighting the importance of their regulation. Many studies mainly focus on inflammation or the relationship between iron homeostasis and OS because iron-dependent cell death has actively been studied. Iron homeostasis is intimately associated with inflammation. However, the interaction of each molecule will need further study to understand the exact connection between them. Furthermore, considering that many molecules require energy for activation, further examination of iron homeostasis and inflammation is needed from the viewpoint of energy metabolism. This will improve the understanding of neurodegenerative diseases.